considerable interest has been drawn by the innovative targeted treatment, osimertinib (same as original) (same as original) (same as original) (same as original) (same as original) (same as original) (same as original) (same as original) (same as original) (same as original), within the domain of glioblastoma therapy.osimertinib (same as original) (same as original) (same as original) (same as original) (same as original) (same as original) (same as original) (same as original) (same as original) (same as original), originally created for lung cancer treatment, has demonstrated encouraging outcomes, in the context…
